Eupraxia Pharmaceuticals Secures C$44.5 Million Investment
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Secures C$44.5 Million Investment
13d ago
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
Premium
Company Announcements
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
17d ago
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
Premium
Company Announcements
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
30d ago
Eupraxia Pharmaceuticals  to present at ISDE Congress for Esophageal Diseases
PremiumThe FlyEupraxia Pharmaceuticals to present at ISDE Congress for Esophageal Diseases
2M ago
Eupraxia’s EP-104GI Shows Promise in EoE Trial
Premium
Company Announcements
Eupraxia’s EP-104GI Shows Promise in EoE Trial
2M ago
Eupraxia reports data from its RESOLVE Phase 1b/2a trial
Premium
The Fly
Eupraxia reports data from its RESOLVE Phase 1b/2a trial
2M ago
Eupraxia CEO to Discuss Osteoarthritis in Upcoming Webinar
PremiumCompany AnnouncementsEupraxia CEO to Discuss Osteoarthritis in Upcoming Webinar
4M ago
Eupraxia Pharmaceuticals Confirms Board and Plans
Premium
Company Announcements
Eupraxia Pharmaceuticals Confirms Board and Plans
5M ago
Eupraxia Reveals Osteoarthritis Treatment Breakthrough
Premium
Company Announcements
Eupraxia Reveals Osteoarthritis Treatment Breakthrough
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100